X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA VENUS REMEDIES SHASUN PHARMA/
VENUS REMEDIES
 
P/E (TTM) x 123.9 -821.4 - View Chart
P/BV x 8.5 0.2 3,552.3% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHASUN PHARMA   VENUS REMEDIES
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
VENUS REMEDIES
Mar-16
SHASUN PHARMA/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs94218 43.2%   
Low Rs4682 55.5%   
Sales per share (Unadj.) Rs214.2365.6 58.6%  
Earnings per share (Unadj.) Rs5.31.5 359.1%  
Cash flow per share (Unadj.) Rs15.837.9 41.7%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.3382.5 13.9%  
Shares outstanding (eoy) m56.6211.44 494.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.4 79.5%   
Avg P/E ratio x13.1101.0 13.0%  
P/CF ratio (eoy) x4.44.0 111.7%  
Price / Book Value ratio x1.30.4 334.1%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,9581,717 230.6%   
No. of employees `000NA1.0 0.0%   
Total wages/salary Rs m2,164324 666.9%   
Avg. sales/employee Rs ThNM4,100.7-  
Avg. wages/employee Rs ThNM318.0-  
Avg. net profit/employee Rs ThNM16.7-  
INCOME DATA
Net Sales Rs m12,1274,183 289.9%  
Other income Rs m22920 1,141.0%   
Total revenues Rs m12,3564,203 294.0%   
Gross profit Rs m1,009812 124.3%  
Depreciation Rs m594417 142.4%   
Interest Rs m415380 109.3%   
Profit before tax Rs m23035 654.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-7318 -401.8%   
Profit after tax Rs m30217 1,777.2%  
Gross profit margin %8.319.4 42.9%  
Effective tax rate %-31.751.6 -61.4%   
Net profit margin %2.50.4 613.0%  
BALANCE SHEET DATA
Current assets Rs m6,8842,771 248.5%   
Current liabilities Rs m8,4561,931 437.8%   
Net working cap to sales %-13.020.1 -64.6%  
Current ratio x0.81.4 56.8%  
Inventory Days Days62125 49.3%  
Debtors Days Days10854 200.1%  
Net fixed assets Rs m4,9705,328 93.3%   
Share capital Rs m113114 99.0%   
"Free" reserves Rs m2,8754,177 68.8%   
Net worth Rs m3,0204,376 69.0%   
Long term debt Rs m1,8171,911 95.1%   
Total assets Rs m13,3478,428 158.4%  
Interest coverage x1.61.1 142.2%   
Debt to equity ratio x0.60.4 137.8%  
Sales to assets ratio x0.90.5 183.1%   
Return on assets %5.44.7 114.1%  
Return on equity %10.00.4 2,575.1%  
Return on capital %13.36.6 201.9%  
Exports to sales %46.40-   
Imports to sales %14.220.5 69.4%   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728858 201.3%   
Fx inflow Rs m5,8430-   
Fx outflow Rs m2,173858 253.2%   
Net fx Rs m3,669-858 -427.5%   
CASH FLOW
From Operations Rs m398469 84.8%  
From Investments Rs m-1,63529 -5,599.3%  
From Financial Activity Rs m1,309-464 -282.3%  
Net Cashflow Rs m7135 206.4%  

Share Holding

Indian Promoters % 39.2 32.9 119.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 0.2 2,000.0%  
FIIs % 17.6 0.6 3,034.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 66.4 59.6%  
Shareholders   20,750 20,121 103.1%  
Pledged promoter(s) holding % 12.3 36.4 33.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   CADILA HEALTHCARE  TTK HEALTHCARE  MERCK LTD  BIOCON LTD  J.B.CHEMICALS  

Compare SHASUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS